30 related articles for article (PubMed ID: 27705736)
1. Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia.
Dafflon C; Craig VJ; Méreau H; Gräsel J; Schacher Engstler B; Hoffman G; Nigsch F; Gaulis S; Barys L; Ito M; Aguadé-Gorgorió J; Bornhauser B; Bourquin JP; Proske A; Stork-Fux C; Murakami M; Sellers WR; Hofmann F; Schwaller J; Tiedt R
Leukemia; 2017 Jun; 31(6):1269-1277. PubMed ID: 27840424
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin.
Svoboda LK; Bailey N; Van Noord RA; Krook MA; Harris A; Cramer C; Jasman B; Patel RM; Thomas D; Borkin D; Cierpicki T; Grembecka J; Lawlor ER
Oncotarget; 2017 Jan; 8(1):458-471. PubMed ID: 27888797
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer.
Sinha KM; Bagheri-Yarmand R; Lahiri S; Lu Y; Zhang M; Amra S; Rizvi Y; Wan X; Navone N; Ozpolat B; Logothetis C; Gagel RF; Huard J
Oncogene; 2019 Jun; 38(25):5038-5049. PubMed ID: 30858546
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of an MLL1 fusion and its role in chromosomal instability.
Parameswaran S; Vizeacoumar FS; Kalyanasundaram Bhanumathy K; Qin F; Islam MF; Toosi BM; Cunningham CE; Mousseau DD; Uppalapati MC; Stirling PC; Wu Y; Bonham K; Freywald A; Li H; Vizeacoumar FJ
Mol Oncol; 2019 Feb; 13(2):422-440. PubMed ID: 30548174
[TBL] [Abstract][Full Text] [Related]
5. Targeting the MLL complex in castration-resistant prostate cancer.
Malik R; Khan AP; Asangani IA; Cieślik M; Prensner JR; Wang X; Iyer MK; Jiang X; Borkin D; Escara-Wilke J; Stender R; Wu YM; Niknafs YS; Jing X; Qiao Y; Palanisamy N; Kunju LP; Krishnamurthy PM; Yocum AK; Mellacheruvu D; Nesvizhskii AI; Cao X; Dhanasekaran SM; Feng FY; Grembecka J; Cierpicki T; Chinnaiyan AM
Nat Med; 2015 Apr; 21(4):344-52. PubMed ID: 25822367
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
7. [Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia].
Zhang LJ; Lu XL; He J; Li Y
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2256-60. PubMed ID: 17064570
[TBL] [Abstract][Full Text] [Related]
8. Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.
Ahlmann M; Meyer C; Marschalek R; Burkhardt B; Koehler G; Klapper W; Juergens H; Rossig C
Eur J Haematol; 2014 Oct; 93(4):349-53. PubMed ID: 24635731
[TBL] [Abstract][Full Text] [Related]
9. MLL translocation in two castration-resistant prostate cancer patients.
Chowdry RP; Ledet E; Ranasinghe L; Sartor AO
Can J Urol; 2016 Oct; 23(5):8483-8486. PubMed ID: 27705736
[TBL] [Abstract][Full Text] [Related]
10. Targeting epigenetic programs in MLL-rearranged leukemias.
Bernt KM; Armstrong SA
Hematology Am Soc Hematol Educ Program; 2011; 2011():354-60. PubMed ID: 22160057
[TBL] [Abstract][Full Text] [Related]
11. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
Chowdhury T; Brady HJ
Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
